EODData

MEMBERSHIP REGISTER LOG IN

FRA, BO1: BioCryst Pharmaceuticals Inc

03 Sep 2026
LAST:

8.682

CHANGE:
 0.11		OPEN:
8.682		HIGH:
8.682		ASK:
0.000		VOLUME:
0
CHG(%):
1.21		PREV:
8.788		LOW:
8.682		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Sep 268.6828.6828.6828.6820
02 Sep 268.4848.7888.4848.7881.5K
31 Aug 268.3568.3568.3568.3560
28 Aug 268.3848.3848.3848.3840
27 Aug 268.3508.3508.3508.3500
26 Aug 268.3328.3328.3328.3320
25 Aug 268.1928.1928.1928.1920
24 Aug 268.1948.1948.1948.1940
21 Aug 268.1708.1708.1708.1700
20 Aug 268.5208.5208.5208.5200

PROFILE

Name:BioCryst Pharmaceuticals Inc
About:BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in phase 1; Avoralstat, an ocular plasma kallikrein inhibitor for diabetic macular edema that is in preclinical phase; and BCX10013, an oral Factor D inhibitor for complement-mediated diseases, as well as developing Oral C5 Inhibitor and Oral C2 Inhibitor. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Shionogi & Co., Ltd., Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Sector:Healthcare
Address:4505 Emperor Boulevard, Durham, NC, United States, 27703
Website:https://www.biocryst.com
ISIN:US09058V1035
LEI:549300Z0INP1Z5NP6J59

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:7.32 
Forward P/E:-11.04 
PEG Ratio:0.01 
Price to Sales:2.22 
Price to Book:-4.58 
Profit Margin:-0.41 
Operating Margin:0.45 
Return on Assets:0.53 
Return on Equity:-2.21 
Revenue:803.65M 
EBITDA:365.14M 
Shares:209.92M 
Market Cap:1.823B 

TECHNICAL INDICATORS

MA5:8.512.0%
MA10:8.403.4%
MA20:8.344.1%
MA50:8.403.4%
MA100:8.008.5%
MA200:7.2320.1%
STO9:82.85 
STO14:82.85 
RSI14:41.63
WPR14:-17.15 
MTM14:0.27
ROC14:0.03 
ATR:0.18 
Week High:8.791.2%
Week Low:8.354.0%
Month High:9.115.0%
Month Low:7.5920.1%
Year High:10.1917.3%
Year Low:5.1867.5%
Volatility:29.02